Toth Financial Advisory Corp Sells 468 Shares of Becton, Dickinson and Company (NYSE:BDX)

Share on StockTwits

Toth Financial Advisory Corp lowered its stake in Becton, Dickinson and Company (NYSE:BDX) by 1.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 23,775 shares of the medical instruments supplier’s stock after selling 468 shares during the period. Toth Financial Advisory Corp’s holdings in Becton, Dickinson and were worth $5,532,000 at the end of the most recent reporting period.

A number of other large investors also recently added to or reduced their stakes in BDX. Mitchell Mcleod Pugh & Williams Inc. boosted its holdings in shares of Becton, Dickinson and by 1.1% during the 2nd quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 3,815 shares of the medical instruments supplier’s stock valued at $913,000 after buying an additional 40 shares in the last quarter. Capital Bank & Trust Co boosted its holdings in shares of Becton, Dickinson and by 21.2% during the 1st quarter. Capital Bank & Trust Co now owns 246 shares of the medical instruments supplier’s stock valued at $57,000 after buying an additional 43 shares in the last quarter. Balentine LLC boosted its holdings in shares of Becton, Dickinson and by 45.3% during the 2nd quarter. Balentine LLC now owns 138 shares of the medical instruments supplier’s stock valued at $33,000 after buying an additional 43 shares in the last quarter. Douglas Lane & Associates LLC boosted its holdings in shares of Becton, Dickinson and by 2.0% during the 2nd quarter. Douglas Lane & Associates LLC now owns 2,443 shares of the medical instruments supplier’s stock valued at $585,000 after buying an additional 47 shares in the last quarter. Finally, Global Retirement Partners LLC boosted its holdings in shares of Becton, Dickinson and by 21.8% during the 2nd quarter. Global Retirement Partners LLC now owns 274 shares of the medical instruments supplier’s stock valued at $66,000 after buying an additional 49 shares in the last quarter. Institutional investors and hedge funds own 84.18% of the company’s stock.

Becton, Dickinson and stock traded up $1.98 during midday trading on Friday, hitting $236.99. The stock had a trading volume of 1,055,055 shares, compared to its average volume of 1,931,858. The firm’s fifty day moving average is $233.68 and its two-hundred day moving average is $247.53. The company has a market capitalization of $68.70 billion, a PE ratio of 85.25, a P/E/G ratio of 2.36 and a beta of 0.84. Becton, Dickinson and Company has a 52-week low of $197.75 and a 52-week high of $286.72. The company has a current ratio of 1.45, a quick ratio of 0.97 and a debt-to-equity ratio of 0.71.

Becton, Dickinson and (NYSE:BDX) last released its earnings results on Thursday, August 6th. The medical instruments supplier reported $2.20 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.04 by $0.16. The company had revenue of $3.86 billion during the quarter, compared to analyst estimates of $3.96 billion. Becton, Dickinson and had a net margin of 5.30% and a return on equity of 14.19%. The firm’s quarterly revenue was down 11.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $3.08 EPS. As a group, equities research analysts predict that Becton, Dickinson and Company will post 9.9 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Wednesday, September 30th. Investors of record on Wednesday, September 9th were issued a $0.79 dividend. This represents a $3.16 annualized dividend and a yield of 1.33%. The ex-dividend date of this dividend was Tuesday, September 8th. Becton, Dickinson and’s dividend payout ratio is 27.05%.

BDX has been the topic of a number of research reports. Morgan Stanley dropped their target price on shares of Becton, Dickinson and from $285.00 to $270.00 and set an “equal weight” rating on the stock in a report on Thursday, August 27th. Barclays upgraded shares of Becton, Dickinson and from an “equal weight” rating to an “overweight” rating and set a $300.00 target price on the stock in a report on Thursday, July 9th. UBS Group upped their price target on shares of Becton, Dickinson and from $265.00 to $280.00 and gave the stock a “neutral” rating in a research note on Monday, August 10th. TheStreet cut shares of Becton, Dickinson and from a “b” rating to a “c+” rating in a research note on Monday, September 21st. Finally, Goldman Sachs Group upgraded shares of Becton, Dickinson and from a “buy” rating to a “conviction-buy” rating in a research note on Friday, October 2nd. One investment analyst has rated the stock with a sell rating, seven have given a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and an average target price of $278.47.

Becton, Dickinson and Company Profile

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company's BD Medical segment offers peripheral IV and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, IV fluids, closed-system drug transfer devices, hazardous drug detection, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, sharps disposal systems; infusion pumps and dedicated disposables, medication compounding workflow systems, automated medication dispensing, automated supply management systems, medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes care; and prefillable drug delivery systems.

Recommended Story: Is it Safe to Invest in Commodities?

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton, Dickinson and Company (NYSE:BDX).

Institutional Ownership by Quarter for Becton, Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply